KR840004436A - 페니실린 유도체의 제조방법 - Google Patents

페니실린 유도체의 제조방법 Download PDF

Info

Publication number
KR840004436A
KR840004436A KR1019830001723A KR830001723A KR840004436A KR 840004436 A KR840004436 A KR 840004436A KR 1019830001723 A KR1019830001723 A KR 1019830001723A KR 830001723 A KR830001723 A KR 830001723A KR 840004436 A KR840004436 A KR 840004436A
Authority
KR
South Korea
Prior art keywords
reaction
oxidation
prepared
derivative
salt
Prior art date
Application number
KR1019830001723A
Other languages
English (en)
Other versions
KR900005046B1 (ko
Inventor
로날드 제이(외4) 미세티크
Original Assignee
고바야시 유끼오
다이호 야꾸힝 고오교 가부시끼가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 고바야시 유끼오, 다이호 야꾸힝 고오교 가부시끼가이샤 filed Critical 고바야시 유끼오
Publication of KR840004436A publication Critical patent/KR840004436A/ko
Application granted granted Critical
Publication of KR900005046B1 publication Critical patent/KR900005046B1/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D499/86—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with only atoms other than nitrogen atoms directly attached in position 6 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

내용 없음

Description

페니실린 유도체의 제조방법
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (5)

  1. 하기식의 페니실린유도체와 제약에 쓸수있는 그 유도체의 염, 그리고 그 유도체의 에스터 제조방법.
    상기식에서 n 은 0,1 또는 2이고 하기식 화합물의 반응단계로 구성되어 있다.
    상기식에서 X 는 염소 또는 브롬원자이고,R은 제약에 쓸수있는 에스터잔류물이다. n은 상기에 표시하였고, 상기 화합물은 금속아자이드와, 그리고 필요할때 산화, 탈-에스터화, 에스터교환, 그리고 염-형성반응중 어느 한 반응을 통해 진행된다.
  2. 제1항에 있어서, 하기식 화합물을 특징으로 하는 제조방법.
    상기식에서 R은 이미 정의하였고, 금속아이드자와 반응이 완결된 후 산화되지 않고 제조되었다.
  3. 제1항에 있어서, 하기식 화합물을 특징으로 하는 제조방법
    상기에서 R은 이미 정의하였고, 금속 아자이드와 반응이 완결된 후 산화시켜 제조되었다.
  4. 제1항에 있어서, 하기식 화합물을 특징으로 하는 제조방법.
    상기에서 n은 0,1 또는 2이고, 금속아자이드와 반응이 종결된 후, 산화되거나 또는 산화되지 않고 탈-에스터화시켜 제조되었다.
  5. 제1항에 있어서, 페니실린 유도체의 염은 금속아자이드와 반응이 종결된 후, 산화되거나 또는 산화되지 않고 효과적인 염-형성반응에 의해 제조되는 것을 특징으로 하는 방법.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019830001723A 1982-04-23 1983-04-23 페니실린 유도체의 제조방법 KR900005046B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP57069142A JPS58185589A (ja) 1982-04-23 1982-04-23 ペニシリン誘導体
JP69142/82 1982-04-23
JP69142 1987-03-25

Publications (2)

Publication Number Publication Date
KR840004436A true KR840004436A (ko) 1984-10-15
KR900005046B1 KR900005046B1 (ko) 1990-07-18

Family

ID=13394097

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019830001723A KR900005046B1 (ko) 1982-04-23 1983-04-23 페니실린 유도체의 제조방법

Country Status (8)

Country Link
US (1) US4507239A (ko)
EP (1) EP0092948B1 (ko)
JP (1) JPS58185589A (ko)
KR (1) KR900005046B1 (ko)
AU (1) AU538789B2 (ko)
CA (1) CA1197840A (ko)
DE (1) DE3369850D1 (ko)
ES (1) ES8502118A1 (ko)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1239392A (en) * 1983-10-13 1988-07-19 Shigeru Yamabe Penicillin derivatives and process for preparing the same
JPS62249988A (ja) * 1986-04-22 1987-10-30 Taiho Yakuhin Kogyo Kk ２β−ハロゲノメチル−２α−メチルペナム−３α−カルボン酸誘導体の製造法
JP2603082B2 (ja) * 1987-09-07 1997-04-23 大塚化学株式会社 ペニシラン酸誘導体の製造法
TW200523264A (en) 2003-10-09 2005-07-16 Otsuka Chemical Co Ltd CMPB crystal and method for producing the same
JP4716708B2 (ja) * 2004-10-28 2011-07-06 大塚化学株式会社 ペナム化合物の製造方法
CN102503956A (zh) * 2011-11-21 2012-06-20 江西华邦药业有限公司 青霉烷二苯甲酯亚砜的制备方法
CN103497203B (zh) * 2013-10-16 2015-09-30 齐鲁天和惠世制药有限公司 一种2β-叠氮甲基-2α-甲基青霉烷-3α-羧酸二苯甲酯的合成方法
CN108997375A (zh) * 2018-08-10 2018-12-14 潍坊奥通药业有限公司 一种6,6-二氢青霉烷酸二苯甲酯-s-亚砜的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4218374A (en) * 1972-10-20 1980-08-19 Fujisawa Pharmaceutical Company, Limited Penam derivatives
US4234579A (en) * 1977-06-07 1980-11-18 Pfizer Inc. Penicillanic acid 1,1-dioxides as β-lactamase inhibitors
US4256733A (en) * 1979-09-26 1981-03-17 Pfizer Inc. Acetoxymethyl penam compounds as β-lactamase inhibitors
FI67553C (fi) * 1980-01-21 1985-04-10 Bristol Myers Co Foerfarande foer framstaellning av en terapeutiskt anvaendbar 2beta-klormetyl-2alfa-metylpenam-3alfa-karboxylsyrasulfon sater och estrar daerav

Also Published As

Publication number Publication date
EP0092948A2 (en) 1983-11-02
CA1197840A (en) 1985-12-10
AU538789B2 (en) 1984-08-30
DE3369850D1 (en) 1987-04-02
EP0092948B1 (en) 1987-02-25
US4507239A (en) 1985-03-26
KR900005046B1 (ko) 1990-07-18
JPS58185589A (ja) 1983-10-29
ES521941A0 (es) 1985-01-01
AU1352783A (en) 1983-10-27
ES8502118A1 (es) 1985-01-01
JPH0124154B2 (ko) 1989-05-10

Similar Documents

Publication Publication Date Title
KR850000406A (ko) 4-클로로-2-페닐이미다졸-5-아세트산유도체의 제조방법
KR830006228A (ko) 이미다졸 유도체의 제조방법
KR830009084A (ko) 퀴놀린 카복실산 유도체의 제조방법
KR840004756A (ko) 항 정신질환제의 제조방법
KR840004436A (ko) 페니실린 유도체의 제조방법
KR830007562A (ko) 퀴놀린 카르복실산 유도체의 제조방법
KR830006154A (ko) 신규의 시클로프로판카르복실레이트의 제조방법
KR830006289A (ko) 5-벤조일-6-클로로(또는 브로모)1,2-디히드로-3H-피롤로[1,2-a]피롤-1-카르복실산 및 이의 유도체의 제조방법
KR830000207A (ko) 아미노-페닐-에탄올 아민과 그의 옥사졸리딘의 제조방법
KR830007604A (ko) 피록시캄의 제조 방법
KR890003819A (ko) 살리실산수지 다가금속화물의 제조방법
KR830003494A (ko) β-락탐에이즈 억제제로서의 아세톡시메틸 페남화합물의 제조방법
KR880011103A (ko) 5-아미노-4,6-디할로게노피리딘의 제조방법
ATE47714T1 (de) Verfahren zur herstellung von n1-methyl-10 alpha- methoxylumilysergol und seine ester, und zwischenverbindungen fuer ihre herstellung.
KR830001952A (ko) 세펄옥심(Cefuroxim)의 제조방법
KR840002766A (ko) 디플루니잘 및 관현 화합물의 1-(알콕시 또는 아르옥시) 카보닐옥시알킬 에스테르의 제조방법
KR850004470A (ko) 유기 화합물의 제조방법
KR900701746A (ko) 2-할로-4-알킬술포닐벤조산의 제조방법
KR850003407A (ko) 유기인산 에스테르 유도체의 제조방법
KR840006810A (ko) 세팔로스포린 에스테르의 제조방법
KR850000390A (ko) 치환된 알칸티오카복실산 유도체의 제조방법
KR830008489A (ko) N-아실 아미노산 유도체의 제조방법
KR840003639A (ko) 이속사졸로피리미딘 유도체의 제조방법
FI851353A0 (fi) Foerfarande foer syntetisering av estrar.
KR830009082A (ko) 퀴놀린 카복실산 유도체의 제조방법

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 19960716

Year of fee payment: 7

LAPS Lapse due to unpaid annual fee